Vijaya Diagnostic Q1 FY27 Net Profit Rises 36% YoY

Board Meeting Details

The Board of Directors meeting was held on Thursday, August 06, 2026, commencing at 18:00 hrs and concluding at 18:45 hrs.

Key Approvals

The Board approved the following:

Unaudited Financial Results of the Company for the first quarter ended June 30, 2026
Standalone and Consolidated Financial Results with Limited Review Reports

Financial Performance (Standalone - Rs. in Lakhs)

Income Statement Q1 FY27 (June 30, 2026)

Revenue from operations: ₹21,853.71 lakhs (23.2% YoY growth from ₹17,736.83 lakhs in Q1 FY26)
Other income: ₹902.01 lakhs
Total income: ₹22,755.72 lakhs

Expenses

Cost of materials consumed: ₹2,431.75 lakhs
Employee benefits expense: ₹3,489.58 lakhs
Finance costs: ₹1,041.78 lakhs
Depreciation and amortization: ₹2,232.73 lakhs
Other expenses: ₹6,468.27 lakhs
Total expenses: ₹15,664.11 lakhs

Profitability

Profit before tax: ₹7,091.61 lakhs (35.0% YoY growth from ₹5,252.79 lakhs)
Tax expense: ₹1,776.85 lakhs (Current tax: ₹1,657.34 lakhs, Deferred tax: ₹119.51 lakhs)
Profit for the period: ₹5,314.76 lakhs (36.1% YoY growth from ₹3,905.02 lakhs)
Other comprehensive income (net of tax): ₹17.12 lakhs
Total comprehensive income: ₹5,331.88 lakhs

Capital Structure

Paid-up equity share capital (Face value Re. 1 each): ₹1,028.97 lakhs
Other equity: ₹93,408.32 lakhs (as of March 31, 2026)

Earnings Per Share

Basic EPS: ₹5.17 (not annualized)
Diluted EPS: ₹5.15 (not annualized)

Comparative Performance

Quarterly Comparison (Standalone)

| Revenue | ₹21,853.71 | ₹20,682.43 | ₹17,736.83 | ₹76,779.09 |

| Net Profit | ₹5,314.76 | ₹5,286.83 | ₹3,905.02 | ₹17,928.19 |

| Basic EPS | ₹5.17 | ₹5.14 | ₹3.80 | ₹17.43 |

Consolidated Financial Highlights (Q1 FY27)

Revenue from operations: ₹23,098.19 lakhs
Profit before tax: ₹7,094.45 lakhs
Total assets: ₹167,693.18 lakhs
Total liabilities: ₹66,490.37 lakhs

Significant Corporate Developments

Business Acquisition

The Board of Directors at its meeting held on May 07, 2026 approved the acquisition of the business of Medinova Millennium MRI Services LLP (100% owned by the Company) by way of slump sale. The transaction has been accounted for using the pooling of interest method under Ind AS 103. Comparative financial information has been restated as if the business combination had occurred from the beginning of the preceding reporting period.

Employee Stock Options

During the quarter ended June 30, 2026, the Company granted 179,500 employee stock options to eligible employees pursuant to the 'Employee Stock Option Plan 2018' as approved by the Nomination and Remuneration Committee on May 07, 2026.

Dividend Proposal

The Board of Directors at its meeting held on May 07, 2026 proposed and recommended a dividend of ₹2 per equity share (200%) for FY 2025-26, subject to shareholder approval at the ensuing Annual General Meeting.

Segment Information

The Company operates in one segment: "Diagnostic services"

Subsidiaries Included in Consolidation

VDC Diagnostic (Karnataka) LLP
Medinova Millennium MRI Services LLP
P H Diagnostic Centre Private Limited

Auditor's Qualifications

Attention drawn to the fact that figures for Q4 FY26 (March 2026) are balancing figures between audited full-year figures and published YTD figures up to Q3 FY26 which were only reviewed, not audited.

Availability of Results

Results available at www.vijayadiagnostic.com, www.nseindia.com and www.bseindia.com